Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laurent Capelle

Showing results (71-80 of 100) with videos related to

Pageof 10
Sort By:
Neuro-Oncology|January 31, 2006
Phase 1 trial of a CpG oligodeoxynucleotide for patients with recurrent glioblastomaAlexandre Carpentier, Florence Laigle-Donadey, Sarah Zohar, et al.
Science Translational Medicine|June 17, 2016
Clinical trial of blood-brain barrier disruption by pulsed ultrasoundAlexandre Carpentier, Michael Canney, Alexandre Vignot, et al.
Neuro-Oncology|February 9, 2013
Velocity of tumor spontaneous expansion predicts long-term outcomes for diffuse low-grade gliomasJohan Pallud, Marie Blonski, Emmanuel Mandonnet, et al.
Journal of Neuro-Oncology|April 14, 2007
French brain tumor data bank: methodology and first results on 10,000 casesLuc Bauchet, Valérie Rigau, Hélène Mathieu-Daudé, et al.
Neuro-Oncology Practice|March 9, 2026
Prognostic factors in adult patients with medulloblastomaYtel Garcilazo-Reyes, Pierre Dal Col, Franck Bielle, et al.
Neuro-Oncology|November 11, 2020
IDH-wildtype lower-grade diffuse gliomas: the importance of histological grade and molecular assessment for prognostic stratificationGiulia Berzero, Anna Luisa Di Stefano, Susanna Ronchi, et al.
Journal of Neuro-Oncology|August 25, 2014
Significant heterogeneity in the geographical distribution of diffuse grade II/III gliomas in FranceAmélie Darlix, Sonia Zouaoui, Jean-Marc Virion, et al.
The Oncologist|July 27, 2019
Molecular Profiling Reclassifies Adult Astroblastoma into Known and Clinically Distinct Tumor Entities with Frequent Mitogen-Activated Protein Kinase Pathway AlterationsWilliam Boisseau, Philipp Euskirchen, Karima Mokhtari, et al.
Clinical Neurology and Neurosurgery|June 20, 2020
Initial surgical resection and long time to occurrence from initial diagnosis are independent prognostic factors in resected recurrent IDH wild-type glioblastomaAntoine Seyve, Fernando Lozano-Sanchez, Alice Thomas, et al.
Journal of Neurosurgery|March 19, 2013
Spontaneous and therapeutic prognostic factors in adult hemispheric World Health Organization Grade II gliomas: a series of 1097 cases: clinical articleLaurent Capelle, Denys Fontaine, Emmanuel Mandonnet, et al.
Pageof 10

Showing results (71-80 of 100) with videos related to

Sort By:
Pageof 10
Neuro-Oncology|January 31, 2006
Phase 1 trial of a CpG oligodeoxynucleotide for patients with recurrent glioblastomaAlexandre Carpentier, Florence Laigle-Donadey, Sarah Zohar, et al.
Science Translational Medicine|June 17, 2016
Clinical trial of blood-brain barrier disruption by pulsed ultrasoundAlexandre Carpentier, Michael Canney, Alexandre Vignot, et al.
Neuro-Oncology|February 9, 2013
Velocity of tumor spontaneous expansion predicts long-term outcomes for diffuse low-grade gliomasJohan Pallud, Marie Blonski, Emmanuel Mandonnet, et al.
Journal of Neuro-Oncology|April 14, 2007
French brain tumor data bank: methodology and first results on 10,000 casesLuc Bauchet, Valérie Rigau, Hélène Mathieu-Daudé, et al.
Neuro-Oncology Practice|March 9, 2026
Prognostic factors in adult patients with medulloblastomaYtel Garcilazo-Reyes, Pierre Dal Col, Franck Bielle, et al.
Neuro-Oncology|November 11, 2020
IDH-wildtype lower-grade diffuse gliomas: the importance of histological grade and molecular assessment for prognostic stratificationGiulia Berzero, Anna Luisa Di Stefano, Susanna Ronchi, et al.
Journal of Neuro-Oncology|August 25, 2014
Significant heterogeneity in the geographical distribution of diffuse grade II/III gliomas in FranceAmélie Darlix, Sonia Zouaoui, Jean-Marc Virion, et al.
The Oncologist|July 27, 2019
Molecular Profiling Reclassifies Adult Astroblastoma into Known and Clinically Distinct Tumor Entities with Frequent Mitogen-Activated Protein Kinase Pathway AlterationsWilliam Boisseau, Philipp Euskirchen, Karima Mokhtari, et al.
Clinical Neurology and Neurosurgery|June 20, 2020
Initial surgical resection and long time to occurrence from initial diagnosis are independent prognostic factors in resected recurrent IDH wild-type glioblastomaAntoine Seyve, Fernando Lozano-Sanchez, Alice Thomas, et al.
Journal of Neurosurgery|March 19, 2013
Spontaneous and therapeutic prognostic factors in adult hemispheric World Health Organization Grade II gliomas: a series of 1097 cases: clinical articleLaurent Capelle, Denys Fontaine, Emmanuel Mandonnet, et al.
Pageof 10